Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Biostem Technologies Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
BSEM
Over the counter
2834
https://www.biostemtechnologies.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Biostem Technologies Inc
BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior Exchange
- Apr 24th, 2024 12:00 pm
BSEM Continues to Post Stellar Results
- Apr 2nd, 2024 12:05 pm
BioStem Technologies to Present at the 14th Annual LD Micro Invitational Conference
- Apr 2nd, 2024 12:00 pm
Q4 2023 Biostem Technologies Inc Earnings Call
- Apr 2nd, 2024 10:31 am
BioStem Technologies Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY Increase
- Apr 1st, 2024 8:05 pm
BioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024
- Mar 21st, 2024 12:00 pm
PRISM MarketView Spotlights BioStem Technologies in the Expanding Wound Care Market
- Feb 26th, 2024 3:39 pm
BSEM: Investors Need to Pay Attention to BSEM
- Feb 1st, 2024 12:07 pm
Amniowrap2™ Product Launch Leads Year of Highlights for BioStem Technologies
- Jan 30th, 2024 9:05 pm
BioStem Technologies Appoints Proven Life Science Sales Leader Shawn McCarrey to Chief Commercial Officer Role
- Jan 11th, 2024 1:30 pm
BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors
- Dec 19th, 2023 1:30 pm
Center for Medicare Services Established National Pricing of AmnioWrap2™ in All MAC Regions
- Dec 14th, 2023 1:30 pm
BioStem Technologies Bolsters Leadership with Appointment of Thomas Dugan to Board of Directors
- Dec 13th, 2023 1:30 pm
BSEM Crushes Estimates on Stellar Growth
- Nov 14th, 2023 12:07 pm
BioStem Technologies Reports Third Quarter 2023 Operating and Financial Results
- Nov 13th, 2023 10:17 pm
BioStem Technologies Awarded Q Code for VENDAJE AC® Line from Centers for Medicare and Medicaid Services
- Nov 8th, 2023 1:30 pm
BioStem Technologies to Report Third Quarter 2023 Financial Results on Tuesday, November 14, 2023
- Nov 6th, 2023 1:30 pm
BioStem Technologies Closes Oversubscribed $2M Private Placement
- Nov 3rd, 2023 12:30 pm
BioStem Technologies Announces Opening of First Clinical Site for Diabetic Foot Ulcer Study
- Oct 24th, 2023 12:30 pm
BioStem Technologies to Present at the Fall Foliage MicroCap Rodeo Conference
- Oct 18th, 2023 12:30 pm
Scroll